Key result
Higher baseline brachial-ankle pulse wave velocity was independently associated with a rapid decline in eGFR in patients with type 2 diabetes (OR 1.072; 95% CI 1.011-1.136).
Why the study?
Is peripheral arterial stiffness associated with a rapid decline in eGFR in patients with type 2 diabetes?
Cohort (n=577)
Is peripheral arterial stiffness associated with a rapid decline in eGFR in patients with type 2 diabetes?
Odds Ratio: 1.072 (95% CI 1.011–1.136)
Brachial-ankle pulse wave velocity (ba-PWV) may serve as a simple, noninvasive predictor of rapid renal function progression in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
May identify T2D patients at higher renal risk; leaves open added value over standard predictors.
Sheen et al. (2013) conducted a cohort in Type 2 diabetes (n=577). Brachial-ankle pulse wave velocity (ba-PWV) was evaluated on Rapid decline in eGFR (progressively lower eGFR at 6- and 12-month visits, plus reduction >3 mL/min/1.73m2 per year) (OR 1.072, 95% CI 1.011-1.136). Higher baseline brachial-ankle pulse wave velocity was independently associated with a rapid decline in eGFR in patients with type 2 diabetes (OR 1.072; 95% CI 1.011-1.136).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: